Patent Application
20240130576
The disclosure herein is directed to a cleansing device that generates and applies a cleansing lather to the body of a user.
Bathing is a means of applying cleansing compositions to skin of a body. The process washes away dead skin cells and clears away dirt, oil, and other contaminants. Various types of soaps, body washes, fragrances, and/or other formulas and mixtures are used for bathing purposes. Devices have been developed for purposes of applying the soap and/or body wash product to the body.
Aspects of the invention are drawn towards a device comprising, a central body, a plurality of dividers, and a handle; the central body comprising a first surface and a second surface; each divider of the plurality of dividers extending upwardly from the first surface of the central body, wherein each divider of the plurality of dividers extends radially from an interior of the first surface to a periphery of the first surface; and a handle attached to the central body. In embodiments, each divider of the plurality of dividers follows a first curved pathway along a first section of the divider. In further embodiments, each divider of the plurality of dividers follows a second curved pathway along a second section of the divider. In embodiments, the first curved pathway comprises a first radius of curvature, wherein the second curved pathway comprises a second radius of curvature. In embodiments, the first radius of curvature is equal to the second radius of curvature. In embodiments, the plurality of dividers comprises a first set of dividers and a second set of dividers. In embodiments, dividers of the first set comprise a first height, wherein dividers of the second set comprise a second height. In embodiments, the first height is different than the second height. In embodiments, the first set of dividers radially extend from a first reference boundary of the interior, wherein the first reference boundary comprises a circle. In embodiments, the second set of dividers radially extend from a second reference boundary of the interior, wherein the second reference boundary comprises a circle. In embodiments, a circumference of the first reference boundary is smaller than a circumference of the second reference boundary. In embodiments, the radially extending plurality of dividers alternate between dividers of the first set and dividers of the second set. In embodiments, an upper edge of each divider comprises a plurality of ridges (e.g., bristles) extending from the upper edge. In embodiments, each ridge of the plurality of ridges comprises a height of 2.5 mm and a width of 1.35 mm. In embodiments, the periphery of the central body comprises a wall surrounding the first surface. The wall can have a raised edge relative to the first surface of the central body. In embodiments, the wall comprises a height of 10.00 mm. In embodiments, an outermost surface (e.g., the wall or another surface) of device forms a polygon. In embodiments, the handle is a strap that is connected to a first side and a second side of the wall, wherein the first side and second side are located on opposing sides of the wall. The strap extends across at least a portion of the second surface of the central body. A user's palm can rest on the second surface to grip the device. In embodiments, the plurality of dividers, the central body, and the handle are integrally formed to have a unitary (e.g., singular) structure that is entirely flexible. In embodiments, the device comprises silicone. In embodiments, an infusement is infused into the silicone. In embodiments, the infusement is infused into the silicone at a concentration of about 20-30 g/kg. In embodiments, the infusement comprises silver phosphate, pyrithione zinc, or a combination thereof. In embodiments, the infusement further comprises a filler. In embodiments, the silver phosphate, pyrithione zinc, or combination thereof comprises about 90% of the infusement and the filler comprises about 10% of the infusement. In embodiments, the infusement comprises about 15 g/kg of silver phosphate and about 15 g/kg of pyrithione zinc. In embodiments, the 15 g/kg of silver phosphate comprises about 10% filler.
Other objects and advantages of this invention will become readily apparent from the ensuing description.
Detailed descriptions of one or more embodiments are provided herein. It is to be understood, however, that the present invention can be embodied in various forms. Therefore, specific details disclosed herein are not to be interpreted as limiting, but rather as a basis for the claims and as a representative basis for teaching one skilled in the art to employ the present invention in any appropriate manner.
The singular forms “a”, “an” and “the” include plural reference unless the context clearly dictates otherwise. The use of the word “a” or “an” when used in conjunction with the term “comprising” in the claims and/or the specification can mean “one,” but it is also consistent with the meaning of “one or more,” “at least one,” and “one or more than one.”
Wherever any of the phrases “for example,” “such as,” “including” and the like are used herein, the phrase “and without limitation” is understood to follow unless explicitly stated otherwise. Similarly, “an example,” “exemplary” and the like are understood to be non-limiting.
The term “substantially” allows for deviations from the descriptor that do not negatively impact the intended purpose. Descriptive terms are understood to be modified by the term “substantially” even if the word “substantially” is not explicitly recited.
The terms “comprising” and “including” and “having” and “involving” (and similarly “comprises”, “includes,” “has,” and “involves”) and the like are used interchangeably and have the same meaning. Specifically, each of the terms is defined consistent with the common United States patent law definition of “comprising” and is therefore interpreted to be an open term meaning “at least the following,” and is also interpreted not to exclude additional features, limitations, aspects, etc. Thus, for example, “a process involving steps a, b, and c” means that the process includes at least steps a, b and c. Wherever the terms “a” or “an” are used, “one or more” is understood, unless such interpretation is nonsensical in context.
As used herein, the term “about” can refer to approximately, roughly, around, or in the region of. When the term “about” is used in conjunction with a numerical range, it modifies that range by extending the boundaries above and below the numerical values set forth. In general, the term “about” is used herein to modify a numerical value above and below the stated value by a variance of 20 percent up or down (higher or lower).
As used herein, the term “substantially the same” or “substantially” can refer to variability typical for a particular method is taken into account.
The terms “sufficient” and “effective”, as used interchangeably herein, can refer to an amount (e.g., mass, volume, dosage, concentration, and/or time period) needed to achieve one or more desired result(s).
Before explaining at least one embodiment of the disclosure in detail, it is to be understood that the disclosure is not necessarily limited in its application to the details set forth in the following description or exemplified by the examples. The disclosure is capable of other embodiments or of being practiced or carried out in various ways. Other compositions, compounds, methods, features, and advantages of the present disclosure will be or become apparent to one having ordinary skill in the art upon examination of the following drawings, detailed description, and examples. All such additional compositions, compounds, methods, features, and advantages can be included within this description, and be within the scope of the present disclosure.
Continuing with the example shown in
As seen in
As seen in
A user may control the scrubbing device by simply extending fingers through the handle with palm facing the lower surface 110 of the central body 104. A user's hand resides within the handle in an interference fit while the user applies the scrubbing device to the body (as further described below). Of course, a user may grip the handle in an alternative fashion. For example, a user may grip the handle using a fist and similarly apply the scrubbing device to target areas of the body.
Scrubbing fins 106 extend upwardly from the upper surface 115 of the scrubbing device. The fins are attached at their proximal ends to an interior portion 150 of the central body's upper surface 115. The fins extend radially from the inner portion 150 of the upper surface 115. The inner portion 150 comprises a first circle 180 and a second circle 182 (seen in broken lines in
The array of fins forms a wave pattern where each fin follows an alternating curved pathway extending from the interior 150 of the central body.
The radially extending plurality of fins circumferentially populate the upper surface 115 of the central body. The fins alternate between a height of 14 mm and 19 mm. Of course, alternative embodiments may include (i) fins of uniform height or (ii) fins of varying heights. If varying in height, the fins may be arranged in circumferentially repeating patterns or in an irregular format. In some embodiments, the fins can be a height of about 3.0 mm, about 3.5 mm, about 4.0 mm, about 4.5 mm, about 5.0 mm, about 5.5 mm, about 6.0 mm, about 6.5 mm, about 7.0 mm, about 7.5 mm, about 8.0 mm, about 8.5 mm, about 9.0 mm, about 9.5 mm, about 10.0 mm, about 10.5 mm, about 11.0 mm, about 11.5 mm, about 12.0 mm, about 12.5 mm, about 13.0 mm, about 13.5 mm, about 14.0 mm, about 14.5 mm, about 15 mm, about 15.5 mm, about 16.0 mm, about 16.5 mm, about 17.0 mm, about 17.5 mm, about 18.0 mm, about 18.5 mm, about 19.0 mm, about 19.5 mm, about 20.0 mm, about 20.5 mm, about 21.0 mm, about 21.5 mm, about 22.0 mm, about 22.5 mm, about 23.0 mm, about 23.5 mm, about 24.0 mm, about 24.5 mm, or about 25 mm.
An upper edge of each fin features a series of ridges. Each ridge is 2.5 mm in height and 1.35 mm in width. The ridges are uniform in height and uniformly distributed along each fin's upper edge. Of course, this height, width, and gap dimension may vary. Further, fins of alternative embodiments may feature ridges of varying shapes, heights, width, and gaps. In some embodiments, the height of the ridge is about 1 mm, about 1.5 mm, about 2 mm, about 2.5 mm, about 3 mm, about 3.5 mm, about 4 mm, about 4.5 mm, or about 5 mm. In some embodiments, the width of the ridge is about 0.5 mm, about 0.55 mm, about 0.6 mm, about 0.65 mm, about 0.7 mm, about 0.75 mm, about 0.8 mm, about 0.85 mm, about 0.9 mm, about 0.95 mm, about 1 mm, about 1.15 mm, about 1.25 mm, about 1.35 mm, about 1.45 mm, about 1.5 mm, about 1.55 mm, about 1.65 mm, about 1.75 mm, about 1.85 mm, about 1.95 mm, about 2 mm, about 2.15 mm, about 2.25 mm, about 2.35 mm, about 2.45 mm, about 2.5 mm, about 2.55 mm, about 2.65 mm, about 2.75 mm, about 2.85 mm, about 2.95 mm, or about 3 mm.
The scrubbing device of
As the device moves across the skin, the fins capture the lather in chambers. The chambers are defined by the upper surface 115 of the device, adjacent fin walls, and skin of the user. As indicated, the fins radially extend from an interior of the central body. With respect to
As one example, the height of the central body 204 is 9.00 mm. In some embodiments, the height of the central body can be about 3.0 mm, about 3.5 mm, about 4.0 mm, about 4.5 mm, about 5.0 mm, about 5.5 mm, about 6.0 mm, about 6.5 mm, about 7.0 mm, about 7.5 mm, about 8.0 mm, about 8.5 mm, about 9.0 mm, about 9.5 mm, about 10.0 mm, about 10.5 mm, about 11.0 mm, about 11.5 mm, about 12.0 mm, about 12.5 mm, about 13.0 mm, about 13.5 mm, about 14.0 mm, about 14.5 mm, or about 15 mm. As another example (as seen in
Described herein are non-limiting embodiments of the materials which can be used to manufacture the scrubber device. It is to be understood that many different materials may be used for forming the scrubber device. For example, materials can include polymers, enhanced polymers, vinyl, polyvinyl chloride (PVC), polydimethylsiloxane (PDMS), fluoropolymers, rubber, metals such as aluminum, steel, copper, and the like, metal composites, carbon fiber, as well as other combinations of materials that are resistant to destruction while preserving the contents of the interior and maintaining sterility within. For example, the scrubber device main body can be formed of a combination of materials making up different components such as silicone, infused silicone and/or rubber. In embodiments, the scrubber device can be manufactured from silicone. As used herein, the term “silicone” can refer to polysiloxane, a polymer of siloxane.
In embodiments, the material used to manufacture the scrubber device can be infused and/or coated with antimicrobial, antifungal, and/or antifouling agents. In embodiments, the scrubber devices can be formed of any suitable mixture, contents, and/or formula and is formed of an antimicrobial infusement. As used herein the term “infusement” can refer to any compound or mixture of compounds that is infused into and/or mixed into the materials used to manufacture the scrubbing device. For example, the scrubber can be manufactured with silicone that is infused with an agent that kills microorganisms and/or stops microorganism growth. Furthermore, in this way, the infused silicone can prevent bacterial growth and/or other growth that leads to unhealthy use such as is found in porous bath and shower devices that have highly porous network of fibers. Examples include a loofah, mesh sponge, or poof devices. Additionally, and in this way, the device can last longer than traditional loofah or other porous bath and shower devices. Additionally, and in this way, the device does not develop odors or other undesirable characteristics, such as with traditional loofah devices or other porous bath and shower devices.
In embodiments, the antimicrobial and/or antifouling agents can include, but are not limited to, silver, silver phosphate, zinc, pyrithione zinc, isothiazolinone, quaternary ammonium, zwitterions, sulfobetaines, triazole compounds, triclosan, benzyalkonium chloride (BAC), chlorhexidine, carboxybetaines, compounds, antibiotics, antifungals, penicillin, aminoglycosides, ofloxacin, erythromycin, tetracycline, chloramphenicol, titanium, cobalt, nickel, zirconium, molybdenum, tin, lead, gold, copper, other metals, a combination thereof, and the like.
In embodiments, the antimicrobial and/or antifouling agents can be present in concentration of about 1 mg/kg, about 10 mg/kg, about 100 mg/kg, about 500 mg/kg, about 1 g/kg, about 5 g/kt, about 10 g/kg, about 15 g/kg, about 25 g/kg, about 50 g/kg, about 100 g/kg, about 500 g/kg, about 1 kg/kg of scrubber body material. For example, the antimicrobial agent is present in a concentration of about 15-30 g/kg of scrubber body material. For example, silver phosphate is infused into silicone at a concentration of about 15-30 g/kg. For example, pyrithione zinc is infused into silicone at a concentration of about 15-30 g/kg. In some embodiments, a combination of silver phosphate and pyrithione zinc is infused into silicone at concentrations of about 15 g/kg and about 15 g/kg respectively.
In embodiments, a combination of silver phosphate at a concentration of about 1 g/kg, about 2 g/kg, about 3 g/kg, about 4 g/kg, about 5 g/kg, about 6 g/kg, about 7 g/kg, about 8 g/kg, about 9 g/kg, about 10 g/kg, about 11 g/kg, about 12 g/kg, about 13 g/kg, about 14 g/kg, about 15 g/kg, about 16 g/kg, about 17 g/kg, about 18 g/kg, about 19 g/kg, about 20 g/kg, about 21 g/kg, about 22 g/kg, about 23 g/kg, about 24 g/kg, about 25 g/kg, about 26 g/kg, about 27 g/kg, about 28 g/kg, about 29 g/kg, or about 30 g/kg and zinc at a concentration of about 1 g/kg, about 2 g/kg, about 3 g/kg, about 4 g/kg, about 5 g/kg, about 6 g/kg, about 7 g/kg, about 8 g/kg, about 9 g/kg, about 10 g/kg, about 11 g/kg, about 12 g/kg, about 13 g/kg, about 14 g/kg, about 15 g/kg, about 16 g/kg, about 17 g/kg, about 18 g/kg, about 19 g/kg, about 20 g/kg, about 21 g/kg, about 22 g/kg, about 23 g/kg, about 24 g/kg, about 25 g/kg, about 26 g/kg, about 27 g/kg, about 28 g/kg, about 29 g/kg, or about 30 g/kg is infused into the body of the scrubber.
As used herein, it is understood that any composition mentioned herein can comprise a certain amount of a filler. For example, the term “silver phosphate,” as used herein, can refer to silver phosphate and a certain amount of a filler. For example, a composition can comprise less than 1% filler, about 2.5% filler, about 5% filler, about 10% filler, about 15% filler, about 20% filler, about 30% filler, about 40% filler, about 50% filler, about 60% filler, about 70% filler, or more than 70% filler.
In embodiments, the scrubber device can be infused with an infusement that is a combination of an antimicrobial and/or antifouling agent and a filler. In one example, the infusement comprises less than 1% filler, about 2.5% filler, about 5% filler, about 10% filler, about 15% filler, about 20% filler, about 30% filler, about 40% filler, about 50% filler, about 60% filler, about 70% filler, or more than 70% filler. In embodiments, the infusement comprises about 90% silver phosphate and about 10% filler. For example, the filler is zeolite. In embodiments, the infusement comprises about 90% pyrithione zinc and about 10% filler. In one example, the filler is zeolite. In embodiments, the scrubber device can be infused with about 15 g/kg of silver phosphate and about 15 g/kg of pyrithione zinc. For example, the scrubber can be infused with about 15 g/kg of about 90% silver phosphate and 10% filler and about 15 g/kg of pyrithione zinc.
As used herein, a filler can refer to a material that is not the antimicrobial and/or antifouling agent. In one example, the filler can improve material properties, reduce cost, or a combination thereof. In embodiments, non-limiting examples of filler can comprise zeolite, glass, nanofillers, polymers, polymer foam beads, fly ashes, calcium carbonate, kaolin, carbon black, talc, mica, silica, zinc oxide, minerals, particulates, fibers, or a combination thereof. As used herein, zeolite can refer to porous aluminosilicate minerals. For example, the zeolite can be a naturally occurring zeolite or a synthetically produced zeolite.
In embodiments, the infused material can be manufactured by heating the scrubber body material to the point of melting and then adding the antimicrobial and/or antifouling agent while mixing. In embodiments, the antimicrobial and/or antifouling agent is homogenously dispersed throughout the material. In one example, the material is silicone, and the antimicrobial agent is silver phosphate. For example, the silver phosphate can be present in an amount of about 20-30 grams of silver phosphate per 1 kg of silicone. In one example, the material is silicone and the antimicrobial agent is pyrithione zinc. In one example, the material is silicone, and the antimicrobial agent is a combination of silver phosphate and pyrithione zinc present in concentrations of about 15 kg/g and about 15 g/kg respective. In one example, the pyrithione zinc can comprise about 10% filler. For example, the filler can be zeolite.
Examples are provided below to facilitate a more complete understanding of the invention. The following examples illustrate the exemplary modes of making and practicing the invention. However, the scope of the invention is not limited to specific embodiments disclosed in these Examples, which are for purposes of illustration only, since alternative methods can be utilized to obtain similar results.
Non-Limiting, Exemplary Antibacterial Testing
The ISO-22196 test is a method of evaluating the antibacterial activity of plastic products. It can be used for evaluating the antimicrobial properties of many material types that can range from coated surfaces or those of monolithic composition. Antimicrobial activity can be determined in the following manner:
R=(Ut−U0)−(At−U0)=Ut−At, wherein
For purposes of common reference, the % reduction is also reported in the notes section of the sample results.
Notation of changes to the published test method:
Several references are made to ‘Plate count agar’ for the test method plating following neutralization and recovery of the bacterial from the test samples. As standard practice, counts are performed on appropriate plate media such as Nutrient agar, tryptic soy agar, or as required by the specific organism tested. The published standard refers to incubation conditions of 35+/−1 C. Standard microbiological practice with other international methods is for incubations to occur at 37 C+/−1 C. The test conditions performed will be conducted at 37 C+/−1 C unless specified for other temperature conditions
Current Laboratory Standard:
Test measurement uncertainty is based on established standard provided in SOP 070601 Measurement Uncertainty Estimates. The measurement uncertainty for this test method can be found in FORM 071102 Bacterial Inoculum OD Correlation Table.
Expanded Uncertainty for the test method of k=2 is for 95% confidence of Log 10 (0.136)
Uncertainty Values in CFU are obtained by converting CFU counts (C1) to Log 10 values (Log 10 C1) multiply this result by the Expanded Uncertainty (Log 10 C1*EU), then add and subtract from the Log 10 value (Log C1+/−(Log 10C1*EU)); convert back by taking the anti-log (1×10{circumflex over ( )}(Log C1+/−(Log 10 C1*EU) which provides the upper and lower limits of 95% confidence in CFU. The antimicrobial performance is reported as both the Log 10 and % reduction relative to the untreated control sample.
Test Sample Result
Introduction
ISO 22196 specifies a method of evaluating the antibacterial activity of plastic products. It is a method commonly used for evaluating the antimicrobial properties of many material types that can range from coated surfaces or those of monolithic composition.
Testing
Inoculum Preparation—following an overnight incubation of the test bacteria, a transfer to the inoculation solution is performed. Transfer the test bacteria into a small about of 1/500 NB prepared. A dilute of this suspension with 1/500 NB is created as appropriate to establish an estimated bacterial concentration, to obtain a bacterial concentration that is between 1E6 CFU/ml and 4E6 CFU/ml, with a target concentration of 2.5E6 CFU/ml
Inoculation of test specimens:
Incubation of the Inoculated Test Specimens
The standard procedure for incubation of the inoculated specimens is to incubate the Petri dishes containing the inoculated test specimens (including half of the untreated test specimens) at a temperature of (37+/−)C and a relative humidity of not less than 90% for (24+/−1)h, unless otherwise noted.
Recovery of Bacteria
After the need plate incubation, count the viable bacteria to determine the recovered bacteria concentrations for each sample replicate
Staphylococcus aureus
Escherichia coli
Sample Preparations
Each test substance was prepared according to the analytic method requirements. Each test sample is prepared in triplicate unless otherwise specified. As available, flat samples are procured, and cut into a piece 50×50 mm. Sample variability is accommodated at needed for the standard test. The test sample will be flat and allow a layering of film over the sample surface during testing. At a minimum, samples will be managed in a way to prevent evaporation of the inoculum from the sample surface during testing, which is confirmed visually following testing. Samples were cut into pieces 40×40 mm
Sampling Procedure
Unless specified, samples will be cut from the provided pieces or used as received if precut. Unless specified, the sample provided is treated as uniform, and monolithic for the purposes of testing, selective cutting, sidedness, or other types of potential sample heterogeneity are disregarded unless instructions for sample handling and noted.
Calculations
Antimicrobial performance==R=(Ut−U0)−(At−U0)=Ut(24 h)−At(24 h), wherein
Table 1 shows the measurement of Antibacterial Activity on Plastic Surfaces.
Table 1 shows results of the ISO-22196 test method to measure the antimicrobial properties of solid or hard surface treated test samples incubated with selected microorganisms. The microorganisms used herein comprise S. aureus and E. coli. In this test method, the bacterial inoculum is in contact with the test sample for a duration of 24 hours without drying of the inoculum. Following this exposure, the inoculated bacteria are recovered, and the concentration of the organisms is determined. The antimicrobial performance is determined by comparison of the recovered organisms from the untreated material and treated material after the 24 hour incubation. The antimicrobial performance is reported as both the Log 10 and % Reduction relative to the untreated control sample. Table 1 shows that the ‘Sud Scrub’ sample resulted in a 4.3 log 10 reduction of S. aureus after 24 hours (i.e., 99.99% reduction) while the untreated control sample increased from 3,340,000 CFU/ml of S. aureus at 0 hrs to 1.03E+07 CFU/ml at 24 hrs of S. aureus. Further, the ‘Sud Scrub’ sample resulted in a 4.7 log 10 reduction of E. coli after 24 hours (i.e., >99.99%) while the untreated control sample increased from 1,320,000 CFU/ml of E. coli at 0 hrs to 1.29E+07 CFU/ml E. coli at 24 hrs.
Resistance of Synthetic Polymeric Materials to Fungi
Method Conventions
The ASTM G21 is a qualitative antimicrobial test used to detect general fungistatic activity on materials. Test results are reported based on a rating scale of 0 to 4 and test notes are provided if a zone of inhibition or contact inhibition is present.
Fungal growth rating:
Note: score “1” is also applicable to trace of growth from extraneous contamination. Non-test organisms are included in the final score; note section will indicate if non-inoculum fungi are present.
Introduction
The ASTM G21 method provides an assessment for fungal resistance of a test material. The test sample is placed onto a nutrient-salt agar and inoculated with a mixed fungal spore inoculum. The inoculum consists of spores derived from A. brasiliensis, P. funiculosum, C. globosum, T. virens, and A. pullulans fungi. Test samples are incubated at 28 C and greater than 90% relative humidity for 28 days. After the incubation period, test samples are visually evaluated for presence and extend of fungal growth. The test result score is based on rating provided by the test method.
Samples are evaluated and assigned a score according to the method scoring scheme. A grid-scale is used to estimate the percent coverage of the test sample based on the microscopic observation using a stereomicroscope.
Test Procedure
Test (
Reagent List: Glass distilled, de-ionized water, Nutrient-salts media.
Equipment List: incubators, stainless steel ruler, temperature logger, hygrometer, stereomicroscope, scoring grid, camera, pipettes.
Test Organisms and Inventor ID/Lot #:_Aureobasidium pullulans (15233), Trichoderma virens (9645), Penicillium funiculosum (11797), Aspergillus brasiliensis (9642), Chaetomium globosum (6205)
Sample Preparation
Standard sample preparation procedure is for 4.8+/−0.1 cm circular samples (
Sampling Procedure
Unless specified, samples are cute from provided pieces or used as received if precut. Unless specified, the sample provided is treated as uniform, and monolithic for the purposes of testing.
Table 2 shows Measurement of Material's Resistance to Fungi
Table 2 shows results of the ASTM G21 standard practice for determining resistance of synthetic polymeric materials to fungi. The ASTM G21 is a qualitative antimicrobial test used to detect general fungistatic activity on materials. The test results are reported based on a rating scale of 0 to 4 and test notes are provided if a zone of inhibition or contact inhibition is present. Fungal growth rating in these results is as follows: 0—no fungal growth, 1—Trace growth (<10% coverage), 2—Light growth (10% to 30% coverage), 3—Medium growth (30% to 60% coverage), and 4—Heavy growth (˜60% to complete coverage). The ‘Sud Scrub’ sample and an Untreated Control sample were inoculated with spores derived from: A. brasiliensis, P. funiculosum, C. globosum, T. virens, and A. pullulans fungi. After 28 days, the ‘Sud Scrub’ sample resulted in a score of 2 while the Untreated Control resulted in a score of 4. It was noted that the ‘Sudscrub’ sample had <30% coverage by fungal mycelia and spore while the Untreated Control sample had >90% full and even coverage by fungal mycelia and spore.
A device is described herein comprising a central body, a plurality of dividers, and a handle. The central body comprises a first surface and a second surface. Each divider of the plurality of dividers extends upwardly from the first surface of the central body, wherein each divider of the plurality of dividers extends radially from an interior of the first surface to a periphery of the first surface. A handle is attached to the central body.
Each divider of the plurality of dividers follows a first curved pathway along a first section of the divider, under an embodiment.
Each divider of the plurality of dividers follows a second curved pathway along a second section of the divider, under an embodiment.
The first curved pathway comprises a first radius of curvature, wherein the second curved pathway comprises a second radius of curvature, under an embodiment.
The first radius of curvature is equal to the second radius of curvature, under an embodiment.
The plurality of dividers of an embodiment comprises a first set of dividers and a second set of dividers.
The dividers of the first set comprise a first height, wherein dividers of the second set comprise a second height, under an embodiment.
The first height is different than the second height, under an embodiment.
The first set of dividers radially extend from a first reference boundary of the interior, wherein the first reference boundary comprises a circle, under an embodiment.
The second set of dividers radially extend from a second reference boundary of the interior, wherein the second reference boundary comprises a circle, under an embodiment.
A circumference of the first reference boundary is smaller than a circumference of the second reference boundary, under an embodiment.
The radially extending plurality of dividers alternate between dividers of the first set and dividers of the second set under, an embodiment.
An upper edge of each divider comprises a plurality of ridges extending from the upper edge, under an embodiment.
Each ridge of the plurality of ridges comprises a height of 2.5 mm and a width of 1.35 mm, under an embodiment.
The periphery of the central body comprises a wall surrounding the first surface, under an embodiment.
The wall comprises a height of 10.00 mm under an embodiment.
The wall comprises a polygon, under an embodiment. The device can form a gap (e.g., a gap 184 in
The handle attaches to a first side and a second side of the wall, wherein the first side and second side are located on opposing sides of the wall, under an embodiment.
The plurality of dividers, the central body, and the handle are integrally formed and entirely flexible, under an embodiment.
The device comprises silicone, under an embodiment.
An infusement is infused into the silicone, under an embodiment.
The infusement is infused into the silicone at a concentration of about 20-30 g/kg, under an embodiment.
The infusement comprises silver phosphate, pyrithione zinc, or a combination thereof, under an embodiment.
The infusement further comprises a filler, under an embodiment.
The silver phosphate, pyrithione zinc, or combination thereof comprises about 90% of the infusement and the filler comprises about 10% of the infusement, under an embodiment.
The infusement comprises about 15 g/kg of silver phosphate and about 15 g/kg of pyrithione zinc, under an embodiment.
The 15 g/kg of silver phosphate comprises about 10% filler, under an embodiment.
Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, numerous equivalents to the specific substances and procedures described herein. Such equivalents are considered to be within the scope of this invention and are covered by the following claims.
This application is a continuation of U.S. patent application Ser. No. 18/320,131, filed on May 18, 2023, which claims priority from U.S. Provisional Application No. 63/370,873, filed on Aug. 9, 2022, the entire contents of which are incorporated herein by reference. All patents, patent applications and publications cited herein are hereby incorporated by reference in their entirety. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art as known to those skilled therein as of the date of the invention described and claimed herein. This patent disclosure contains material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the U.S. Patent and Trademark Office patent file or records, but otherwise reserves any and all copyright rights.
| Number | Date | Country | |
|---|---|---|---|
| 63370873 | Aug 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 18320131 | May 2023 | US |
| Child | 18401216 | US |
